| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0004358> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0005525> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0021054> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0021083> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0026896> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0751339> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C0751340> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C1527392> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C4761103> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32833750_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.\', \'Neuroimmunology Unit, National and Kapodistrian University of Athens Medical School, Athens, Greece.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Dalakas_Marinos_C>
?:doi	10.1097/WCO.0000000000000858
?:doi	<https://research.tib.eu/covid-19/entity/10.1097/WCO.0000000000000858>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Current opinion in neurology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32833750> <https://research.tib.eu/covid-19/entity/euyyr9wv>
?:pmid	<https://research.tib.eu/covid-19/entity/32833750>
?:pmid	32833750
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.929
?:rankingScore_hIndex	107
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0003242_INTERACTS_WITH_C1414557> <https://research.tib.eu/covid-19/entity/C0009498_TREATS_C0027765> <https://research.tib.eu/covid-19/entity/C0026896_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0270942_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0393022_ASSOCIATED_WITH_C0026896> <https://research.tib.eu/covid-19/entity/C0393022_TREATS_C0026896> <https://research.tib.eu/covid-19/entity/C0814128_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C1414557_TREATS_C0027765>
?:title	Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32833750>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32833750>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all